F · Healthcare

H. LUNDBECK A/S SER.B DK1 (LDBA)

Drug Manufacturers - Specialty & Generic

H. LUNDBECK A/S SER.B DK1 (LDBA) is listed on F in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-29, reported market cap is $5.14B, P/E ratio is 12.06, net margin is 13.0%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Key metrics for LDBA

Market cap
$5.14B
P/E ratio
12.06
Gross profit (TTM)
$20.37B
Net margin
13.0%

H. LUNDBECK A/S SER.B DK1 (LDBA) — FAQ

What is H. LUNDBECK A/S SER.B DK1's market cap?

H. LUNDBECK A/S SER.B DK1 (LDBA) has a reported market cap of $5.14B (data as of 2026-03-29).

What is LDBA's P/E ratio?

The price-to-earnings (P/E) ratio for H. LUNDBECK A/S SER.B DK1 (LDBA) is 12.06 (data as of 2026-03-29).

Does H. LUNDBECK A/S SER.B DK1 pay a dividend?

Dividend yield is not available in the current snapshot for H. LUNDBECK A/S SER.B DK1 (LDBA). Check the MyAverix Finance app for the latest dividend data.

What sector is H. LUNDBECK A/S SER.B DK1 in?

H. LUNDBECK A/S SER.B DK1 (LDBA) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).

What exchange is LDBA listed on?

LDBA is listed on F.

What is H. LUNDBECK A/S SER.B DK1's net margin?

H. LUNDBECK A/S SER.B DK1 (LDBA) reports a net margin of 13.0% (data as of 2026-03-29).

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

App Store Google Play